Parnassus Endeavor Fund MRK trades
Parnassus Investments
Parnassus Endeavor Fund Merck & Company Inc stake
total: 118
Trades details
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 2
- Held since:
- 2021 Q4
- Held for:
- 7 quarters
- Latest activity:
- 2023 Q3
According to 2026 Q2 report, Parnassus Endeavor Fund doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $76.64 for "buy" trades and estimated average "sell" price is $114.67. Parnassus Endeavor Fund first purchased MRK in 2021 Q4, initially acquiring about 2.31M shares. Since the initial investment in Merck & Company Inc (MRK), Parnassus Endeavor Fund has made 3 more transactions.
When did Parnassus Endeavor Fund sell Merck & Company Inc (MRK)?
Parnassus Endeavor Fund sold off the entire Merck & Company Inc (MRK) position in 2023 Q3.
When did Parnassus Endeavor Fund buy Merck & Company Inc (MRK)?
Parnassus Endeavor Fund first invested in Merck & Company Inc (MRK) in 2021 Q4 at the reported quarter-end price of $76.64 per share.
What's the cost basis of Parnassus Endeavor Fund's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $76.64 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $76.64
- Weighted AVG sell price:
- $114.67
Parnassus Endeavor Fund's historical trades in Merck & Company Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q3
|
0.00%
|
0
|
$115.39
|
|
-100% (-1,337,970)
|
-3.3%
|
|
2023 Q2
|
3.30%
|
1,337,970
|
$115.39
|
$154,388,358
|
-30.74% (-593,737)
|
-1.47%
|
|
2022 Q4
|
4.66%
|
1,931,707
|
$110.95
|
$214,322,892
|
-16.25% (-374,841)
|
-1%
|
|
2021 Q4
|
3.26%
|
2,306,548
|
$76.64
|
$176,773,839
|
new
|
+3.26%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.